|
Development of Attentional Biases for Affective Cues in Infants of Mothers With Depression
RECRUITINGN/ASponsored by Binghamton University
Actively Recruiting
PhaseN/A
SponsorBinghamton University
Started2024-11-14
Est. completion2029-02
Eligibility
Age6 Months+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT06835855
Summary
The goal of this study is to examine attentional biases for facial displays of emotion as a mechanism of risk in infants of mothers with postpartum major depression, and the potential role of infant arousal in the development of these attentional biases.
Eligibility
Age: 6 Months+Healthy volunteers accepted
Inclusion Criteria: * The high-risk group (n = 150) will consist of women with at least one episode of MDD since their baby's birth. * To qualify for the low-risk group (n = 75), women cannot have a history of any depressive disorder or any current psychiatric diagnoses. * Infants will be required to be singleton children born full-term (\> 37 weeks) and normal weight (\> 2,500 grams) with no birth complications or health problems to avoid medical complications contributing to infants' attention, reactivity, and regulation measures. * The two groups will be matched on demographic factors (e.g., age, race/ethnicity, income). Exclusion Criteria: * Additional exclusion criteria are diagnoses of alcohol or substance use disorders currently or at any point during pregnancy, or lifetime history of bipolar or psychotic disorders.
Conditions2
DepressionDepression - Major Depressive Disorder
Locations1 site
Binghamton University
Binghamton, New York, 13902
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorBinghamton University
Started2024-11-14
Est. completion2029-02
Eligibility
Age6 Months+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT06835855